GlycoNex

Beyond's analysis on GlycoNex

• 2026-08-03 — GlycoNex initiates first-in-human Phase I trial of its glycan-targeted ADC GNX1021 in Japan

Recent news mentioning GlycoNex

• 2026-08-03 — GlycoNex Doses First Patient in Phase I Trial of GNX1021, Advancing Its Glycan-Directed ADC into Clinical Development

Appears alongside

• ADC

Browse the full archive →